These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma. Ascierto PA; Schadendorf D J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990 [TBL] [Abstract][Full Text] [Related]
5. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948 [TBL] [Abstract][Full Text] [Related]
6. Treatment approaches of advanced cutaneous squamous cell carcinoma. Peris K; Piccerillo A; Del Regno L; Di Stefani A J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():19-22. PubMed ID: 34855254 [TBL] [Abstract][Full Text] [Related]
7. Systemic therapy for advanced cutaneous squamous cell carcinoma. Fitzgerald K; Tsai KK Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028 [TBL] [Abstract][Full Text] [Related]
8. Cemiplimab for locally advanced cutaneous squamous cell carcinoma: safety, efficacy, and position in therapy panel. Lebas E; Marchal N; Rorive A; Nikkels AF Expert Rev Anticancer Ther; 2021 Apr; 21(4):355-363. PubMed ID: 33554680 [TBL] [Abstract][Full Text] [Related]
9. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma. Hernández-Guerrero T; Doger B; Moreno V Drugs Today (Barc); 2019 Aug; 55(8):485-494. PubMed ID: 31461085 [TBL] [Abstract][Full Text] [Related]
10. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma. Villani A; Ocampo-Garza SS; Potestio L; Fabbrocini G; Ocampo-Candiani J; Ocampo-Garza J; Scalvenzi M Expert Opin Drug Saf; 2022 Jan; 21(1):21-29. PubMed ID: 34644510 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma. Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660 [TBL] [Abstract][Full Text] [Related]
18. PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma. Joseph K; Walker J; Raziee H; Faruqi S; Smylie M J Cutan Med Surg; 2022; 26(3):243-248. PubMed ID: 34866423 [TBL] [Abstract][Full Text] [Related]
19. [Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab]. Vanhakendover L; Lebas E; Libon F; Wauters O; Dezfoulian B; Marchal N; Rorive A; Piret P; Quatresooz P; Jacquemin D; Nikkels AF Rev Med Liege; 2019 Jul; 74(7-8):436-440. PubMed ID: 31373461 [TBL] [Abstract][Full Text] [Related]
20. Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios. Akhtar K; Sravanthi MV; D'Angelo J; Sivapiragasam A J Investig Med High Impact Case Rep; 2022; 10():23247096221121408. PubMed ID: 36017984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]